GTx-024 as a Treatment for Stress Urinary Incontinence in Women: A Proof of Concept Study

Trial Profile

GTx-024 as a Treatment for Stress Urinary Incontinence in Women: A Proof of Concept Study

Active, no longer recruiting
Phase of Trial: Phase II

Latest Information Update: 05 Mar 2018

At a glance

  • Drugs Enobosarm (Primary)
  • Indications Stress incontinence; Urinary incontinence
  • Focus Proof of concept; Therapeutic Use
  • Sponsors GTx
  • Most Recent Events

    • 05 Mar 2018 Results presented at the Society of Urodynamics, Female Pelvic Medicine, & Urogenital Reconstruction (SUFU) 2018 Meeting, according to a GTx, Inc. media release.
    • 05 Mar 2018 Results presented in a GTx, Inc. media release.
    • 22 Feb 2018 According to a GTx media release, data will be presented at the Society of Urodynamics, Female Pelvic Medicine, & Urogenital Reconstruction 2018 Winter Meeting
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top